BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 48 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,654,000 | -77.6% | 2,510,000 | -76.4% | 0.00% | -75.0% |
| Q3 2017 | $11,869,000 | -16.0% | 10,639,000 | -16.6% | 0.01% | -14.3% |
| Q2 2017 | $14,133,000 | +8.1% | 12,754,000 | +10.2% | 0.01% | +16.7% |
| Q1 2017 | $13,072,000 | -1.6% | 11,574,000 | -2.5% | 0.01% | -7.7% |
| Q4 2016 | $13,278,000 | -44.4% | 11,875,000 | -40.4% | 0.01% | -43.5% |
| Q3 2016 | $23,896,000 | +15.7% | 19,923,000 | +9982.0% | 0.02% | 0.0% |
| Q2 2016 | $20,662,000 | -29.4% | 197,610 | -99.2% | 0.02% | -34.3% |
| Q1 2016 | $29,271,000 | +380.8% | 25,275,000 | +433.0% | 0.04% | +400.0% |
| Q4 2015 | $6,088,000 | -6.2% | 4,742,000 | -5.6% | 0.01% | -12.5% |
| Q3 2015 | $6,492,000 | -25.9% | 5,025,000 | -11.6% | 0.01% | -11.1% |
| Q2 2015 | $8,759,000 | -18.2% | 5,683,000 | -21.0% | 0.01% | -18.2% |
| Q1 2015 | $10,710,000 | -25.6% | 7,197,000 | -41.2% | 0.01% | -15.4% |
| Q4 2014 | $14,387,000 | +37.6% | 12,238,000 | +23.9% | 0.01% | +44.4% |
| Q3 2014 | $10,458,000 | -21.2% | 9,878,000 | -23.0% | 0.01% | -18.2% |
| Q2 2014 | $13,266,000 | +336.2% | 12,825,000 | +362.2% | 0.01% | +266.7% |
| Q1 2014 | $3,041,000 | -1.9% | 2,775,000 | -5.1% | 0.00% | 0.0% |
| Q4 2013 | $3,099,000 | – | 2,925,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ferox Capital Management LP | 6,000,000 | $6,271,000 | 4.60% |
| Weiss Asset Management LP | 27,058,000 | $28,040,000 | 2.16% |
| Birch Grove Capital LP | 4,643,000 | $4,802,000 | 1.91% |
| CSS LLC/IL | 20,256,000 | $20,993,000 | 0.89% |
| PIPER SANDLER & CO. | 1,000,000 | $1,036,000 | 0.86% |
| AQR Arbitrage LLC | 24,825,000 | $25,686,000 | 0.30% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 17,000,000 | $17,589,000 | 0.20% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,000,000 | $5,182,000,000 | 0.12% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,107,000 | $4,256,000 | 0.12% |
| Verition Fund Management LLC | 3,106,000 | $3,214,000 | 0.12% |